Mersana, Endo Pharmaceuticals to develop antibody-drug conjugates
Mersana Therapeutics has signed a collaboration agreement with Endo Pharmaceuticals to develop next-generation antibody-drug conjugates (ADCs). Under the deal, Endo will pay an upfront fee to Mersana for
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.